WO2004070383A3 - Identifizierung schmerzegulierter gene im drg nach cfa-arthritits - Google Patents
Identifizierung schmerzegulierter gene im drg nach cfa-arthritits Download PDFInfo
- Publication number
- WO2004070383A3 WO2004070383A3 PCT/EP2003/013597 EP0313597W WO2004070383A3 WO 2004070383 A3 WO2004070383 A3 WO 2004070383A3 EP 0313597 W EP0313597 W EP 0313597W WO 2004070383 A3 WO2004070383 A3 WO 2004070383A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pain
- drg
- cfa
- identification
- dorsal root
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003289947A AU2003289947A1 (en) | 2003-02-05 | 2003-12-02 | Identification of pain-regulated gene in the dorsal root ganglion (drg) after cfa-induced arthritis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10304680 | 2003-02-05 | ||
DE10304680.1 | 2003-02-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004070383A2 WO2004070383A2 (de) | 2004-08-19 |
WO2004070383A3 true WO2004070383A3 (de) | 2005-03-03 |
Family
ID=32841599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/013597 WO2004070383A2 (de) | 2003-02-05 | 2003-12-02 | Identifizierung schmerzegulierter gene im drg nach cfa-arthritits |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003289947A1 (de) |
WO (1) | WO2004070383A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE460476T1 (de) * | 2006-09-22 | 2010-03-15 | Visgeneer Inc | Menschliche protein phosphatase mit ef-hände-1 (ppef-1)- ähnliches genvariant assoziert mit t- zellen lymphoblastisches lymphom |
CN111620942B (zh) * | 2020-06-12 | 2021-10-15 | 中国科学院昆明动物研究所 | 布氏鼠耳蝠白三烯A4水解酶抑制剂Motistin的成熟肽及其应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0478146A1 (de) * | 1990-08-31 | 1992-04-01 | The Wistar Institute | DNS und Polypeptide von tumorassoziiertem Antigen CO-029 |
WO2000034470A1 (en) * | 1998-12-10 | 2000-06-15 | Song, Huaidong | Npcbac06: human transitional endoplasmic reticulum atpase gene |
WO2000075339A1 (en) * | 1999-06-03 | 2000-12-14 | Cold Spring Harbor Laboratory | Substrate trapping protein tyrosine phosphatases |
US6274312B1 (en) * | 1996-12-11 | 2001-08-14 | Schering Corporation | Intracellular regulatory molecules; related reagents |
WO2002012338A2 (de) * | 2000-08-03 | 2002-02-14 | Grünenthal GmbH | Screeningverfahren |
WO2003004606A2 (en) * | 2001-07-03 | 2003-01-16 | The Trustees Of Columbia University In The City Of New York | Antisense oligonucleotides and related methods for regulating cell death |
WO2003014322A2 (en) * | 2001-08-08 | 2003-02-20 | Incyte Genomics, Inc. | Proteins associated with cell growth, differentiation, and death |
-
2003
- 2003-12-02 AU AU2003289947A patent/AU2003289947A1/en not_active Abandoned
- 2003-12-02 WO PCT/EP2003/013597 patent/WO2004070383A2/de not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0478146A1 (de) * | 1990-08-31 | 1992-04-01 | The Wistar Institute | DNS und Polypeptide von tumorassoziiertem Antigen CO-029 |
US6274312B1 (en) * | 1996-12-11 | 2001-08-14 | Schering Corporation | Intracellular regulatory molecules; related reagents |
WO2000034470A1 (en) * | 1998-12-10 | 2000-06-15 | Song, Huaidong | Npcbac06: human transitional endoplasmic reticulum atpase gene |
WO2000075339A1 (en) * | 1999-06-03 | 2000-12-14 | Cold Spring Harbor Laboratory | Substrate trapping protein tyrosine phosphatases |
WO2002012338A2 (de) * | 2000-08-03 | 2002-02-14 | Grünenthal GmbH | Screeningverfahren |
WO2003004606A2 (en) * | 2001-07-03 | 2003-01-16 | The Trustees Of Columbia University In The City Of New York | Antisense oligonucleotides and related methods for regulating cell death |
WO2003014322A2 (en) * | 2001-08-08 | 2003-02-20 | Incyte Genomics, Inc. | Proteins associated with cell growth, differentiation, and death |
Non-Patent Citations (10)
Title |
---|
CHEN H ET AL: "Cloning of the cDNA for a human homolog of the rat PEP-19 gene and mapping to chromosome 21q22.2-q22.3.", HUMAN GENETICS. DEC 1996, vol. 98, no. 6, December 1996 (1996-12-01), pages 672 - 677, XP002304432, ISSN: 0340-6717 * |
CHEN S-L ET AL: "SEQUENCE OF A MURINE COMPLEMENTARY DNA PCP-4 THAT ENCODES THE HOMOLOG OF THE RAT BRAIN-SPECIFIC ANTIGEN PEP-19", NUCLEIC ACIDS RESEARCH, vol. 18, no. 5, 1990, pages 1304, XP008038366, ISSN: 0305-1048 * |
CLAAS CHRISTOPH ET AL: "Association between the rat homologue of CO-029, a metastasis-associated tetrspanin molecule and consumption coagulopathy", JOURNAL OF CELL BIOLOGY, vol. 141, no. 1, 6 April 1998 (1998-04-06), pages 267 - 280, XP002304438, ISSN: 0021-9525 * |
HUANG XIZHONG ET AL: "Molecular cloning, expression, and characterization of a novel human serine/threonine protein phosphatase, PP7, that is homologous to Drosophila retinal degeneration C gene product (rdgC)", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 273, no. 3, 16 January 1998 (1998-01-16), pages 1462 - 1468, XP002304437, ISSN: 0021-9258 * |
LEE MAUD WAN-YING ET AL: "Restricted expression of LUZP in neural lineage cells: A study in embryonic stem cells", JOURNAL OF BIOMEDICAL SCIENCE, vol. 8, no. 6, November 2001 (2001-11-01), pages 504 - 511, XP002294582, ISSN: 1021-7770 * |
MONTINI E ET AL: "A novel human serine-threonine phosphatase related to the Drosophila retinal degeneration C (rdgC) gene is selectively expressed in sensory neurons of neural crest origin", HUMAN MOLECULAR GENETICS, vol. 6, no. 7, 1997, pages 1137 - 1145, XP002304435, ISSN: 0964-6906 * |
SANGAMESWARAN LAKSHMI ET AL: "Structure and regulation of the gene encoding the neuron-specific protein PEP-19", MOLECULAR BRAIN RESEARCH, vol. 19, no. 1-2, 1993, pages 62 - 68, XP002304433, ISSN: 0169-328X * |
SHERMAN PATTI M ET AL: "Identification and characterization of a conserved family of protein serine/threonine phosphatases homologous to Drosophila retinal degeneration C (rdgC)", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 94, no. 21, 1997, pages 11639 - 11644, XP002304436, ISSN: 0027-8424 * |
SUN DER-SHAN ET AL: "Identification, molecular characterization, and chromosomal localization of the cDNA encoding a novel leucine zipper motif-containing protein", GENOMICS, vol. 36, no. 1, 1996, pages 54 - 62, XP002294583, ISSN: 0888-7543 * |
SZALA S ET AL: "MOLECULAR CLONING OF COMPLEMENTARY DNA FOR THE HUMAN TUMOR-ASSOCIATED ANTIGEN CO-029 AND IDENTIFICATION OF RELATED TRANSMEMBRANE ANTIGENS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 87, no. 17, 1990, pages 6833 - 6837, XP002304439, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
AU2003289947A8 (en) | 2004-08-30 |
AU2003289947A1 (en) | 2004-08-30 |
WO2004070383A2 (de) | 2004-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005084158A3 (en) | Polypeptide transduction and fusogenic peptides | |
WO2004074455A3 (en) | Fc REGION VARIANTS | |
WO2005030797A3 (en) | Melanocortin receptor agonists | |
WO2001068859A3 (en) | Il-17 receptor like molecules and uses thereof | |
RS92704A (en) | Immunoglobulin-domain containing cell surface recognition molecules | |
WO2002012338A3 (de) | Screeningverfahren | |
WO2006047728A3 (en) | Bmp gene and fusion protein | |
WO2006122971A3 (en) | Treatment of disease using an improved regulated expression system | |
WO2002083713A3 (en) | Echinocandin process | |
WO2004070383A3 (de) | Identifizierung schmerzegulierter gene im drg nach cfa-arthritits | |
WO2003093419A3 (en) | Preventing secondary lymphedema with vegf-d dna | |
WO2001059120A3 (en) | Il-17 like molecules and uses thereof | |
WO2003066879A3 (en) | Amino acid transporters | |
WO2004078918A3 (en) | Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides | |
WO2001044283A3 (en) | Human ion channels | |
WO2004026895A3 (en) | Gd2 ligands | |
WO2005023979A3 (en) | Isolated s. mansoni nucleic acid molecules and uses thereof | |
WO2006000464A3 (de) | Verfahren zum auffinden schmerzrelevanter substanzen unter verwendung schmerzrelevanter proteine | |
WO2002101394A3 (de) | Screeningverfahren mit bnpi und dnpi | |
EP1634951A4 (de) | Neues protein | |
WO2002070563A3 (en) | Nuclear hormone receptor ligand binding domain | |
WO2004019976A3 (en) | Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides | |
WO2003022883A3 (de) | Verwendung eines proteins zur herstellung eines medikaments zur stimulierung des angeborenen unspezifischen immunsystems | |
WO2004076613A3 (de) | Humane nukleinsäuresequenzen aus harnblasenkarzinomen | |
WO2004009633A8 (en) | Serotonin receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |